spacer
 
|

Click below to register.

Friday, October 13, 2017
Denver Convention Center

700 14th Street
Denver, Colorado
Room: Mile High 1DEF

6:15 AM – 6:45 AM: Registration and Breakfast
6:45 AM – 8:00 AM: Interactive CME Activity

OVERVIEW
Children with cerebral palsy (CP) may present with a variety of functional problems and gait disorders due to various impairments, including muscle overactivity, loss of selective motor control, and disturbances of sensation. In order to set appropriate individualized treatment goals, it is imperative to assess the impact of spasticity and other impairments on the patient’s overall function and quality of life. This live symposium will provide participants with the opportunity to optimize the diagnosis and the management of spasticity in patients with CP, through appropriate evaluation techniques, individualized goal-setting, and evidence-based treatment selection. In addition, data and remaining challenges resulting from recent clinical trials will be addressed. Case presentations will be used to discuss the process of goal setting and treatment selection with attention given to the role of botulinum toxin alone and in combination with other treatment modalities.

GOAL
The goal of this activity is to provide physiatrists, neurologists, and other healthcare professionals involved in the care of children with CP with the most up-to-date clinical knowledge and strategies for the optimal diagnosis and management of patients with CP-related spasticity.

LEARNING OBJECTIVES
Upon completion of this activity, the participant should be able to:
  • RECOGNIZE spasticity in children with CP and strategies to establish individualized treatment goals.
  • ASSESS the efficacy and safety data on available pharmacological and non-pharmacological strategies to manage spasticity in children with CP.
  • EVALUATE the use of BoNT as part of individualized treatment plans for managing spasticity in children with CP.
AGENDA
6:15 – 6:45 AM Registration and Breakfast
6:45 – 7:00 AM Overview and Activity Goals
Katherine E. Alter, MD
7:00 – 7:45 AM Video Case Presentations Covering
  • Recognition and effects on function
  • Developing individualized treatment goals, including functional goals
  • Safety and efficacy of available pharmacotherapies
  • Dosing, formulation, muscle selection, and injection technique for BoNT
  • Communicating with patients and caregivers regarding the benefits and risks of BoNT
Faculty Panel
7:45 – 8:00 AM Question and Answer Session/Conclusions
Faculty Panel

This schedule is subject to change.

PARTICIPATING FACULTY
Katharine E. Alter, MD (Course Director)
Senior Physiatrist
Mount Washington Pediatric Hospital
Clinical Assistant Professor, Pediatrics, Physical Medicine Rehabilitation
AT Still University
Mesa, Arizona

Mauricio R. Delgado, MD
Professor of Neurology
University of Texas Southwestern Medical Center
Director of Pediatric Neurology and Neurorehabilitation
Texas Scottish Rite Hospital for Children
Dallas, Texas

Mark Gormley, Jr, MD
Pediatric Rehabilitation Medicine Physician
Section Chief
Pediatric Physical Medicine and Rehabilitation
Gillette Children’s Specialty Healthcare
Saint Paul, Minnesota

TARGET AUDIENCE
This initiative is intended for physiatrists, neurologists, and other healthcare professionals involved in the care of patients with spasticity.

METHOD OF PARTICIPATION
This program consists of live faculty lectures enhanced by slide presentations, case vignettes, and question and answer periods. This live activity will incorporate audience participation (eg, discussion, ARS keypads) to ensure an interactive meeting and engender a collegial atmosphere that facilitates the open exchange of ideas. The course sessions will provide a complete review and study of current treatment and management practices for patients with spasticity.

ACCREDITATION
In support of improving patient care, this activity has been planned and implemented by Dannemiller and ASiM CE, LLC. Dannemiller is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
Dannemiller designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMERICANS WITH DISABILITIES ACT (ADA)
Dannemiller and ASiM fully comply with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Adrienne Roser at ASiM CE by e-mail at aroser@asimcme.com or 908-253-9001 ext. 23 by October 10, 2017 in order to receive service.

FEE INFORMATION
There is no fee for this educational activity.

TECHNICAL QUESTIONS
Please contact ASiM at 908-253-9001 or webmaster@asimcme.com.


Submit a case to review at meeting:


<img src="http://www.jhasio1.com/asim/pictures/proceed_pretestASIM.png" alt="procced to pretest" border="0" />


spacer  
  spacer
Advanced Studies in Medicine © 2014 Contact Us
spacer  
spacer